News
Important Only
Stocks
Summit Therapeutics falls after mixed data from late-stage cancer trial
** Shares of drug developer Summit Therapeutics SMMT.O fall 20.2% to $20.91 ** Co says its experimental lung cancer therapy ivonescimab in combination with chemotherapy showed a positive trend in overall survival, but "without achieving a statistically significant benefit" in a global late-s...Reuters
Fri, May 30
Other
Universal secures $2.526 billion cat reinsurance limit for 2025, adds multi-year coverage
By Navneeta NandanMay 30 - (The Insurer) - Universal Insurance Holdings has secured a combined reinsurance limit of $2.526 billion for its insurance company subsidiaries for the 2025/26 policy year, an increase of $110 million on the previous policy year.The combined tower, which covers Universal Pr...Reuters
Fri, May 30
Other
France's Macron calls for Asian coalitions as he warns of US-China divisions
French leader called for independent coalitions in Indo-PacificMacron says not solving Ukraine crisis will hurt credibility in AsiaMacron is visiting region as France, Asia aim to strengthen tiesBy Fanny Potkin, Xinghui Kok and Idrees Ali SINGAPORE, May 30 (Reuters) - French President Emmanuel Ma...Reuters
Fri, May 30
Forex
Mexican Peso gains as US PCE softens, consumer sentiment in focus
The Mexican Peso (MXN) is strengthening against the US Dollar (USD) in the early hours of the American session on Friday after the release of soft inflation data in the United States, with the pair remaining vulnerable to broader geopolitical risks.
Fxstreet
Fri, May 30
Other
Siddhi Acquisition Corp Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing June 4, 2025
May 30 (Reuters) - Siddhi Acquisition Corp SDHIU.O:SIDDHI ACQUISITION CORP ANNOUNCES THE SEPARATE TRADING OF ITS ORDINARY SHARES AND RIGHTS, COMMENCING JUNE 4, 2025Reuters
Fri, May 30
Other
ESS Confirms Path To Continued Execution Of Its Strategic Plan With The Energy Base
May 30 (Reuters) - Ess Tech Inc GWH.N:ESS CONFIRMS PATH TO CONTINUED EXECUTION OF ITS STRATEGIC PLAN WITH THE ENERGY BASEESS TECH INC - ANNOUNCES POTENTIAL WORKFORCE ACTIONS IF CAPITAL NOT RAISEDReuters
Fri, May 30
Stocks
2 Unstoppable Vanguard ETFs That Have Doubled in Just 5 Years
Investing in exchange-traded funds (ETFs) is usually associated with safe and stable long-term investing. But not all ETFs are the same. And just because you invest in one doesn't mean you can't still earn a great return.Two ETFs that have produced some fantastic returns for investors in the past fi...The Motley Fool
Fri, May 30
Commodities
Gunvor, SOCAR neck and neck to buy refiner Italiana Petroli, sources say
By Francesca Landini and Valentina ZaMILAN, May 30 (Reuters) - Global commodity trader Gunvor and State Oil Company of Azerbaijan (SOCAR) are neck and neck in the race to buy oil refiner Italiana Petroli, three sources close to the matter said on Friday, as an end-May deadline to submit final offers...Reuters
Fri, May 30
Stocks
Nordson rises after Oppenheimer upgrades to 'outperform'
** Dispensing equipment maker Nordson Corp NDSN.O shares up 1.3% at $212, in early morning trade** Oppenheimer upgrades co's rating to 'outperform' from 'perform' after co on Wednesday posted Q2 earnings that beat analysts' estimates** Brokerage reiterates price target at $26...Reuters
Fri, May 30
Other
BioLineRx To Present New Pilot Phase Data From Phase 2 Combination Trial Of Motixafortide At ASCO 2025 Annual Meeting
May 30 (Reuters) - BioLine RX Ltd BLRX.TA:BIOLINERX ANNOUNCES NEW PILOT PHASE DATA FROM PHASE 2 COMBINATION TRIAL OF MOTIXAFORTIDE IN FIRST-LINE PANCREATIC CANCER (PDAC) TO BE PRESENTED AT ASCO 2025 ANNUAL MEETINGBIOLINE RX LTD - TRIAL TO BE FULLY ENROLLED IN 2027Reuters
Fri, May 30
